✦ LIBER ✦

Benefit-Risk Assessment of Exenatide in the Therapy of Type 2 Diabetes Mellitus

✍ Scribed by Professor Dr Baptist Gallwitz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Exenatide enhances standard therapy in t

✍ Innes,, C 📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 199 KB

A Risk-Benefit Assessment of Metformin i

✍ Dr Harry C. S. Howlett, Clifford J. Bailey 📂 Article 📅 1999 🏛 Springer International Publishing AG 🌐 English ⚖ 188 KB

Exenatide beneficial in type 2 diabetes

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

The assessment of cardiovascular risk in

✍ Hancu, N.; Cerghizan, Anca 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Cardiovascular risk assessment in type 2

✍ Ebaa Al-Ozairi; R. Jan-Willem Middelbeek; Edward S. Horton 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 85 KB

Benefits of lipid-lowering therapy in pa

✍ John Betteridge 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 205 KB